IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.924
EU - Europa 11.524
AS - Asia 10.267
SA - Sud America 1.834
AF - Africa 238
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 21
Totale 46.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.620
PL - Polonia 3.957
CN - Cina 3.813
SG - Singapore 3.154
UA - Ucraina 2.108
BR - Brasile 1.533
DE - Germania 1.465
HK - Hong Kong 1.213
IT - Italia 1.118
VN - Vietnam 683
FI - Finlandia 660
GB - Regno Unito 602
RU - Federazione Russa 411
TR - Turchia 388
IE - Irlanda 370
IN - India 331
FR - Francia 222
CA - Canada 148
BD - Bangladesh 140
SE - Svezia 118
CZ - Repubblica Ceca 101
AR - Argentina 100
ZA - Sudafrica 100
ES - Italia 98
ID - Indonesia 91
MX - Messico 90
JP - Giappone 85
NL - Olanda 79
EC - Ecuador 59
IQ - Iraq 54
PK - Pakistan 43
AT - Austria 42
IR - Iran 42
BE - Belgio 41
MA - Marocco 41
CO - Colombia 38
VE - Venezuela 33
SA - Arabia Saudita 25
KE - Kenya 24
CL - Cile 23
AU - Australia 22
CH - Svizzera 20
LT - Lituania 20
EU - Europa 19
IL - Israele 19
MU - Mauritius 19
PE - Perù 19
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
AZ - Azerbaigian 16
PY - Paraguay 15
KZ - Kazakistan 14
JO - Giordania 13
KR - Corea 13
PA - Panama 13
PH - Filippine 13
EG - Egitto 12
TH - Thailandia 12
TN - Tunisia 11
RO - Romania 10
DZ - Algeria 9
MY - Malesia 9
BG - Bulgaria 8
KG - Kirghizistan 8
LK - Sri Lanka 8
LV - Lettonia 8
BO - Bolivia 7
CU - Cuba 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
LB - Libano 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
GE - Georgia 6
GR - Grecia 6
NP - Nepal 6
NZ - Nuova Zelanda 6
SN - Senegal 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AL - Albania 5
HR - Croazia 5
HU - Ungheria 5
NO - Norvegia 5
BY - Bielorussia 4
EE - Estonia 4
HN - Honduras 4
AO - Angola 3
BH - Bahrain 3
CR - Costa Rica 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GD - Grenada 2
IS - Islanda 2
Totale 46.808
Salva come PNG Salva come JPEG
Città #
Warsaw 3.947
Fairfield 3.026
Woodbridge 2.187
Ashburn 2.001
Jacksonville 1.580
Houston 1.512
Singapore 1.502
Hong Kong 1.201
Ann Arbor 1.179
Cambridge 1.173
Seattle 1.101
Wilmington 1.062
Beijing 880
Chandler 798
Princeton 669
Nanjing 581
New York 479
Los Angeles 412
Brescia 381
Dublin 366
The Dalles 360
Dearborn 337
Dallas 323
Helsinki 308
Istanbul 302
Munich 222
Ho Chi Minh City 196
Dong Ket 181
Nanchang 180
San Francisco 161
Buffalo 160
Moscow 160
São Paulo 157
Shenyang 151
Des Moines 149
Hebei 144
Jinan 142
Changsha 139
San Diego 132
Shanghai 126
Milan 125
Chicago 115
Lancaster 104
Tianjin 103
Hanoi 101
Jiaxing 101
Redondo Beach 96
Santa Clara 94
London 91
Tokyo 80
Boardman 77
Kunming 73
Turku 69
Brooklyn 68
Phoenix 67
Brno 64
Jakarta 64
Hangzhou 63
San Mateo 61
Madrid 54
Guangzhou 53
Johannesburg 53
Verona 53
Orem 50
Haikou 48
Toronto 47
Boston 46
Rome 45
Rio de Janeiro 44
Zhengzhou 44
Augusta 43
Ningbo 43
Stockholm 43
Lanzhou 42
Nuremberg 39
Montreal 38
Chennai 37
Denver 37
Belo Horizonte 35
Brussels 35
Council Bluffs 35
Kocaeli 35
Leawood 33
Poplar 33
Washington 33
Atlanta 32
Porto Alegre 32
Charlotte 31
Amsterdam 30
Fuzhou 29
Mexico City 29
Taizhou 28
Curitiba 27
Changchun 26
Haiphong 26
Olomouc 26
Dhaka 25
Hefei 25
Kilburn 25
Ardabil 24
Totale 33.196
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 325
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 324
The nanostructured secretome 321
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 308
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 303
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 300
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 290
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 286
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 284
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 277
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 274
Claudin3 is localized outside the tight junctions in human carcinomas 274
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 271
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 267
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 266
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 264
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 263
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 262
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 261
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 259
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 259
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 256
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 254
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 253
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 253
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 251
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 249
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 249
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 246
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 241
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 241
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 238
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 235
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 233
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 233
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 222
Zebrafish disease models in hematology: Highlights on biological and translational impact 218
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 213
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 212
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 210
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 205
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 202
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 202
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 199
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 198
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 198
Long pentraxin-3 follows and modulates bladder cancer progression 198
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 197
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 195
Anti-angiogenic activity of the purine analog 6-thioguanine. 195
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 194
The zebrafish/tumor xenograft angiogenesis assay. 194
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 192
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 191
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 190
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 189
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 188
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 187
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 183
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 182
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 182
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 181
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 181
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 178
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 175
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 175
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 174
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 173
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 172
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 171
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 171
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 170
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 170
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 169
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 169
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 168
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 167
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 166
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 165
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 165
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 164
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 164
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 163
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 162
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 162
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 161
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 161
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 160
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 160
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 160
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 159
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 158
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 158
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 157
Beta-Galactosylceramidase deficiency: neurovascular implications 157
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 157
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 157
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 156
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 155
Totale 20.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 207.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 207.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.934 0 0 0 0 0 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/20268.042 1.327 1.675 1.078 1.838 1.441 683 0 0 0 0 0 0
Totale 47.584